Before starting, a doctor must screen for contraindications, medical conditions that make these drugs unsafe
As of February 2026, Eli Lilly plans to submit orforglipron for FDA approval as a diabetes treatment sometime in 2026
The choice of best alternative depends entirely on your individual needs, such as preference for a pill, need for the highest efficacy, or budget constraints
This combined approach supports long-term weight management by fostering healthier habits and coping strategies
Numbness or tingling- Some numbness or tingling in the treated area may happen
Medical disclaimer: This page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment